Plasma High Molecular Weight Kininogen Concentration in Health and in Chosen Impairments of Haemostasis. Evidence that Plasmin Uncovers a New Antigenic Site in High Molecular Weight Kininogen

Józef Kleniewski

doi:10.1055/s-0038-1656996

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1979; 42(03): 1046-1055
DOI: 10.1055/s-0038-1656996

Original Article

Schattauer GmbH Stuttgart

Plasma High Molecular Weight Kininogen Concentration in Health and in Chosen Impairments of Haemostasis. Evidence that Plasmin Uncovers a New Antigenic Site in High Molecular Weight Kininogen

Józef Kleniewski

The Department of Cell Pathophysiology, Postgraduate Medical School, Warsaw, Poland

› Author Affiliations

Abstract

PDF Download

Summary

High molecular weight kininogen (HMW-kininogen) concentration was measured in the plasma of healthy blood donors, patients with haemophilia A, idiopathic thrombocytopoenic purpura, deep vein thrombosis treated with oral anticoagulants and patients treated with streptokinase (SK). The concentration of HMW-kininogen in the plasma of healthy subjects was 92 ± 15 μg/ml. The values obtained in patients’ plasma were not different statistically. In the plasma of patients treated with repeated infusion of SK, a significant increase of HMW-kininogen antigen activity was noted after each injection of the drug. Similar results were obtained when SK was added to plasma “in vitro” or when a purified preparation of HMW-kininogen was treated with plasmin. These and additional data obtained suggest that plasmin uncovers in the HMW-kininogen molecule a new antigenic site(s) common to HMW-kininogen and low molecular weight kininogen and new antigenic site(s) specific only for HMW-kininogen.

PDF (392 kb)

References

References
1 Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavay M, Guimaraes JA, Pierce JV, Kaplan AP, Weinstein L. 1975; Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Journal of Clinical Investigation 56: 1650
2 Deutsch DG, Mertz ET. 1970; Plasminogen: purification from human plasma by affinity chromatography. Science (Wash. D. C.) 170: 1095
3 Donaldson VH, Saito H, Ratnoff OD. 1974; Defective esterase and kinin-forming activity in human Fletcher trait plasma: a fraction rich in kallikrein-like activity. Circulation Research 34: 652
4 Donaldson VH, Glueck HI, Miller MA, Movat HZ, Habal F. 1976; Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. Journal of Laboratory and Clinical Medicine 87: 327
5 Donaldson VH, Kleniewski J, Saito H, Kernan-Sayed J. 1977; Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald factor clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. Journal of Clinical Investigation 60: 571
6 Guimaraes JA, Chenlu R, Webster ME, Pierce JV. 1974; Multiple forms of human plasma kininogen. Federation Proceedings 33: 641
7 Jacobsen S, Kriz M. 1967; Some data on two purified kininogens from human plasma. British Journal of Pharmacology 29: 25
8 De Jalon PG, Bayo Bayo YM, De Jalon MG. 1945; Sensible y nuevo metods de valorecion de andrendina en utero osseaus de rata. Farmacoterapia 2: 313
9 Kleniewski J, Donaldson VH. 1977; Quantitation of high molecular weight kininogen (HMW- KGN) by specific hemagglutination inhibition reaction. Proceedings of the Society for Experimental Biology and Medicine 156: 117
10 Laurell CB, Laurell S, Skoog N. 1956; Buffer composition in paper electrophoresis: consideration on its influence with special reference to the interaction between smal ions and proteins. Clinical Chemistry 2: 99
11 Laurell CB. 1966; Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anals of Biochemistry 15: 45
12 Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265
13 Mancini G, Carbonara AO, Heremans JF. 1965; Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235
14 Pierce JV. 1968; Structural features of plasma kinins and kininogens. Federation Proceedings 27: 52
15 Proctor RR, Rapaport SI. 1961; The partial thromboplastin time with kaolin. American Journal of Clinical Pathology 36: 212
16 Saito H, Ratnoff OD, Waldmann R, Abraham JP. 1974; Impaired Hageman factor (factor XII) dependent reaction in Fitzgerald trait. Blood 44: 934 A
17 Saito H, Ratnoff OD, Waldmann R, Abraham JP. 1975; Fitzgerald trait: deficiency of hitherto unrecognized agent, Fitzgerald factor participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins and property of diluted plasma enhancing vascular permeability (PF/dil). Journal of Clinical Investigation 55: 1082
18 Saito H, Goldsmith G, Waldmann R. 1976; Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasmas. Blood 48: 941
19 Schiffman S, Lee P. 1975; Partial purification and characterization of contact activation co-factor. Journal of Clinical Investigation 56: 1082
20 Wuepper KD, Cochrane CG. 1971. Isolation and mechanism of activation of components of the plasma kinin-forming system. In Austen KF, Becker EL. (ed.) Biochemistry of the Acute Allergic Reactions. Blackwell Scientific; Philadelphia: 299
21 Wuepper KD, Miller DR, Lacombe MJ. 1975; Flaujeac trait: deficiency of human plasma kininogen. Journal of Clinical Investigation 56: 1663